Nifty

:

25239.10

Sensex

:

82380.69

169.90 (0.68%)
594.95 (0.73%)

Login

Nifty
Sensex

:
:

25239.10
82380.69

169.90 (0.68%)
594.95 (0.73%)

Bal Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

47/99

BSE: 524824 | NSE: BALPHARMA

Watchlist

NSE BSE

88.98

16-Sep-2025

Open
High
Low
Previous Close

88
91.73
87.67
87.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

30387
2719724.28
140.95
78.06

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

141.62
19.79
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

283.98
1.35%
1.82

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.13
14.67
6.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.36
44.58
5.76

PAT CAGR (%)

10 Years
5 Years
3 Years

7.41
-
9.67

P:E (Median)

8 Years
5 Years
3 Years

31.04
28.30
36.93

P:BV (Average)

8 Years
5 Years
3 Years

2.04
2.39
2.41

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.23
10.36
9.36

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 65.64 73.13 -10.24% 81.78 94.58 -13.53% 72.89 81.50 -10.56% 74.70 92.30 -19.07%
Expenses 59.48 66.56 -10.64% 73.95 85.40 -13.41% 65.16 73.87 -11.79% 67.22 84.65 -20.59%
EBITDA 6.15 6.56 -6.25% 7.83 9.18 -14.71% 7.73 7.63 1.31% 7.48 7.65 -2.22%
EBIDTM 9.38% 8.97% 9.58% 9.71% 10.60% 9.36% 10.01% 8.29%
Other Income 0.74 0.29 155.17% 0.99 1.86 -46.77% 0.82 0.26 215.38% 0.35 0.41 -14.63%
Interest 4.05 3.71 9.16% 3.94 3.34 17.96% 5.01 3.66 36.89% 4.18 3.82 9.42%
Depreciation 2.52 2.43 3.70% 2.07 2.14 -3.27% 2.33 2.55 -8.63% 2.12 2.01 5.47%
PBT 0.32 0.72 -55.56% 2.82 5.55 -49.19% 1.20 1.67 -28.14% 1.52 2.23 -31.84%
Tax 0.00 0.36 -100.00% -2.79 0.21 - 0.05 0.42 -88.10% 0.32 0.63 -49.21%
PAT 0.32 0.36 -11.11% 5.61 5.34 5.06% 1.16 1.26 -7.94% 1.20 1.60 -25.00%
PATM 0.49% 0.49% 6.86% 5.65% 1.58% 1.54% 1.61% 1.74%
EPS 0.20 0.23 -13.04% 3.53 3.36 5.06% 0.73 0.79 -7.59% 0.76 1.01 -24.75%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 65.87 74.36 -11.42% 81.88 94.63 -13.47% 73.15 81.66 -10.42% 73.69 92.54 -20.37%
Expenses 59.81 67.89 -11.90% 74.23 85.03 -12.70% 65.40 73.87 -11.47% 66.00 84.84 -22.21%
EBITDA 6.06 6.47 -6.34% 7.64 9.59 -20.33% 7.76 7.80 -0.51% 7.70 7.70 0.00%
EBIDTM 9.20% 8.69% 9.33% 10.14% 10.61% 9.55% 10.44% 8.32%
Other Income 0.72 0.82 -12.20% 1.08 2.45 -55.92% 0.51 0.10 410.00% -0.21 0.14 -
Interest 4.05 4.24 -4.48% 3.95 4.14 -4.59% 5.01 3.66 36.89% 3.65 3.82 -4.45%
Depreciation 2.52 2.43 3.70% 2.18 2.16 0.93% 2.69 2.96 -9.12% 2.48 2.42 2.48%
PBT 0.21 0.62 -66.13% 2.59 5.75 -54.96% 0.57 1.27 -55.12% 1.36 1.60 -15.00%
Tax 0.00 0.36 -100.00% -2.83 0.22 - 0.05 0.42 -88.10% 0.32 0.63 -49.21%
PAT 0.21 0.26 -19.23% 5.42 5.53 -1.99% 0.52 0.85 -38.82% 1.04 0.97 7.22%
PATM 0.32% 0.35% 6.62% 5.85% 0.71% 1.04% 1.41% 1.05%
EPS 0.13 0.16 -18.75% 3.41 3.46 -1.45% 0.30 0.56 -46.43% 0.65 0.60 8.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 295.01 338.54 303.10 280.37 249.31 170.67 223.08 207.66 225.96 197.66 187.13 Net Sales Growth -13.62% 11.69% 8.11% 12.46% 46.08% -23.49% 7.43% -8.10% 14.32% 5.63% Cost Of Goods Sold 152.34 175.78 156.11 152.53 140.49 75.84 103.69 87.91 103.73 93.97 87.48 Gross Profit 142.67 162.76 146.99 127.84 108.81 94.84 119.39 119.74 122.24 103.69 99.65 GP Margin 48.36% 48.08% 48.50% 45.60% 43.64% 55.57% 53.52% 57.66% 54.10% 52.46% 53.25% Total Expenditure 265.81 305.92 276.67 256.93 222.81 163.66 202.59 184.76 205.85 180.52 169.60 Power & Fuel Cost - 7.57 6.87 5.37 4.70 4.68 6.38 6.06 6.17 4.65 4.54 % Of Sales - 2.24% 2.27% 1.92% 1.89% 2.74% 2.86% 2.92% 2.73% 2.35% 2.43% Employee Cost - 56.11 51.56 44.46 39.62 48.78 48.45 49.61 41.35 35.67 31.96 % Of Sales - 16.57% 17.01% 15.86% 15.89% 28.58% 21.72% 23.89% 18.30% 18.05% 17.08% Manufacturing Exp. - 34.03 34.02 26.62 19.21 15.94 20.42 17.99 21.25 19.69 20.77 % Of Sales - 10.05% 11.22% 9.49% 7.71% 9.34% 9.15% 8.66% 9.40% 9.96% 11.10% General & Admin Exp. - 11.34 9.16 7.95 4.97 7.09 8.61 10.26 16.08 13.69 12.31 % Of Sales - 3.35% 3.02% 2.84% 1.99% 4.15% 3.86% 4.94% 7.12% 6.93% 6.58% Selling & Distn. Exp. - 18.61 16.68 16.75 10.00 10.10 13.71 12.64 16.41 12.36 11.88 % Of Sales - 5.50% 5.50% 5.97% 4.01% 5.92% 6.15% 6.09% 7.26% 6.25% 6.35% Miscellaneous Exp. - 2.48 2.27 3.27 3.82 1.22 1.32 0.27 0.86 0.47 11.88 % Of Sales - 0.73% 0.75% 1.17% 1.53% 0.71% 0.59% 0.13% 0.38% 0.24% 0.35% EBITDA 29.19 32.62 26.43 23.44 26.50 7.01 20.49 22.90 20.11 17.14 17.53 EBITDA Margin 9.89% 9.64% 8.72% 8.36% 10.63% 4.11% 9.19% 11.03% 8.90% 8.67% 9.37% Other Income 2.90 3.35 2.19 6.46 2.69 3.63 2.75 1.67 3.39 1.50 1.19 Interest 17.18 15.42 12.59 10.60 12.14 12.69 12.71 9.39 8.46 6.48 6.52 Depreciation 9.04 8.45 7.48 7.24 7.26 7.03 6.12 6.73 6.46 6.97 7.00 PBT 5.86 12.11 8.55 12.06 9.80 -9.08 4.41 8.45 8.59 5.18 5.20 Tax -2.42 1.83 2.42 3.48 0.70 -0.17 -2.35 2.52 3.28 2.38 1.18 Tax Rate -41.30% 15.11% 28.30% 28.86% 7.14% 1.87% -53.29% 29.82% 38.18% 45.95% 22.69% PAT 8.29 10.27 6.13 8.58 9.10 -8.90 6.76 5.94 5.31 2.81 4.02 PAT before Minority Interest 8.29 10.27 6.13 8.58 9.10 -8.90 6.76 5.94 5.31 2.81 4.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.81% 3.03% 2.02% 3.06% 3.65% -5.21% 3.03% 2.86% 2.35% 1.42% 2.15% PAT Growth -3.15% 67.54% -28.55% -5.71% - - 13.80% 11.86% 88.97% -30.10% EPS 5.21 6.46 3.86 5.40 5.72 -5.60 4.25 3.74 3.34 1.77 2.53

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 294.59 339.22 304.22 281.21 250.53 171.09 225.01 209.29 228.91 198.32 187.16 Net Sales Growth -14.16% 11.50% 8.18% 12.25% 46.43% -23.96% 7.51% -8.57% 15.42% 5.96% Cost Of Goods Sold 152.35 175.79 158.95 155.74 140.87 75.74 104.04 88.57 103.94 94.06 87.49 Gross Profit 142.24 163.43 145.27 125.48 109.66 95.35 120.96 120.71 124.97 104.25 99.67 GP Margin 48.28% 48.18% 47.75% 44.62% 43.77% 55.73% 53.76% 57.68% 54.59% 52.57% 53.25% Total Expenditure 265.44 307.51 278.97 257.24 225.88 166.07 207.33 191.95 214.10 183.46 170.05 Power & Fuel Cost - 8.73 7.73 5.89 4.98 4.76 6.38 6.07 6.17 4.66 4.54 % Of Sales - 2.57% 2.54% 2.09% 1.99% 2.78% 2.84% 2.90% 2.70% 2.35% 2.43% Employee Cost - 60.38 55.30 47.25 41.88 50.44 50.28 52.16 45.37 37.30 32.24 % Of Sales - 17.80% 18.18% 16.80% 16.72% 29.48% 22.35% 24.92% 19.82% 18.81% 17.23% Manufacturing Exp. - 29.09 27.76 21.92 18.62 15.80 20.28 18.03 21.44 19.80 20.78 % Of Sales - 8.58% 9.12% 7.79% 7.43% 9.23% 9.01% 8.61% 9.37% 9.98% 11.10% General & Admin Exp. - 11.96 10.16 8.07 5.47 7.48 9.27 11.21 16.82 13.98 12.43 % Of Sales - 3.53% 3.34% 2.87% 2.18% 4.37% 4.12% 5.36% 7.35% 7.05% 6.64% Selling & Distn. Exp. - 18.99 16.36 14.86 10.28 10.61 15.74 15.63 19.50 13.18 11.91 % Of Sales - 5.60% 5.38% 5.28% 4.10% 6.20% 7.00% 7.47% 8.52% 6.65% 6.36% Miscellaneous Exp. - 2.57 2.72 3.51 3.79 1.23 1.33 0.27 0.86 0.47 11.91 % Of Sales - 0.76% 0.89% 1.25% 1.51% 0.72% 0.59% 0.13% 0.38% 0.24% 0.35% EBITDA 29.16 31.71 25.25 23.97 24.65 5.02 17.68 17.34 14.81 14.86 17.11 EBITDA Margin 9.90% 9.35% 8.30% 8.52% 9.84% 2.93% 7.86% 8.29% 6.47% 7.49% 9.14% Other Income 2.10 2.85 0.94 5.15 1.14 1.85 1.01 1.73 3.04 1.28 1.17 Interest 16.66 15.44 12.31 10.91 12.16 12.73 12.74 9.41 8.49 6.48 6.52 Depreciation 9.87 10.07 9.13 9.04 9.52 7.68 6.16 6.77 6.49 7.01 7.02 PBT 4.73 9.05 4.75 9.18 4.10 -13.53 -0.20 2.88 2.87 2.65 4.74 Tax -2.46 1.60 2.13 3.48 -0.61 -0.64 -2.36 2.51 3.27 2.39 1.19 Tax Rate -52.01% 17.68% 44.84% 37.91% -14.88% 4.73% 1180.00% 87.15% 113.94% 90.19% 25.11% PAT 7.19 7.40 2.57 5.61 4.74 -12.22 3.79 2.79 1.75 1.41 3.62 PAT before Minority Interest 7.16 7.45 2.62 5.70 4.71 -12.89 2.15 0.38 -0.40 0.26 3.55 Minority Interest -0.03 -0.05 -0.05 -0.09 0.03 0.67 1.64 2.41 2.15 1.15 0.07 PAT Margin 2.44% 2.18% 0.84% 1.99% 1.89% -7.14% 1.68% 1.33% 0.76% 0.71% 1.93% PAT Growth -5.52% 187.94% -54.19% 18.35% - - 35.84% 59.43% 24.11% -61.05% EPS 4.52 4.65 1.62 3.53 2.98 -7.69 2.38 1.75 1.10 0.89 2.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 105.58 96.03 87.32 79.32 65.94 76.86 72.23 66.59 56.70 55.60 Share Capital 15.80 15.69 14.82 14.82 14.17 14.17 14.17 14.17 12.87 12.87 Total Reserves 89.11 78.95 70.65 63.56 51.77 62.69 58.06 52.41 41.81 40.71 Non-Current Liabilities 46.56 39.52 36.34 35.35 33.42 37.24 45.53 29.94 26.02 16.33 Secured Loans 23.21 14.11 27.01 23.93 22.93 28.76 33.25 12.76 10.81 6.11 Unsecured Loans 13.14 16.42 0.00 0.00 0.22 0.00 1.43 5.04 5.13 0.53 Long Term Provisions 4.93 4.91 4.60 3.97 3.55 2.66 2.02 3.35 2.23 1.65 Current Liabilities 209.16 212.15 166.10 146.87 139.95 143.06 133.33 122.32 110.61 92.22 Trade Payables 89.84 90.77 72.20 48.55 39.45 47.49 49.95 53.55 46.75 38.49 Other Current Liabilities 26.17 27.80 23.65 22.30 29.40 26.55 31.73 15.42 11.53 11.77 Short Term Borrowings 89.99 86.95 65.11 75.05 70.61 68.06 49.29 52.05 50.09 40.14 Short Term Provisions 3.15 6.63 5.14 0.97 0.49 0.96 2.37 1.29 2.24 1.83 Total Liabilities 361.30 347.70 289.76 261.54 239.31 257.16 251.09 218.85 193.33 164.15 Net Block 64.56 63.07 52.90 52.65 56.14 56.94 58.28 59.72 55.95 51.90 Gross Block 117.25 107.22 92.12 86.13 82.36 76.19 71.43 66.14 105.77 96.00 Accumulated Depreciation 52.69 44.15 39.22 33.48 26.23 19.25 13.15 6.42 49.82 44.10 Non Current Assets 80.16 77.75 71.56 68.34 70.60 68.66 69.62 68.49 68.89 59.50 Capital Work in Progress 0.47 0.00 1.16 0.00 0.11 0.06 0.21 1.70 3.93 0.77 Non Current Investment 9.58 8.40 8.40 8.40 7.42 7.44 7.44 0.02 1.18 1.09 Long Term Loans & Adv. 5.10 4.51 6.29 4.80 5.38 1.68 3.13 6.59 7.52 5.39 Other Non Current Assets 0.45 1.78 2.82 2.49 1.56 2.54 0.55 0.46 0.32 0.34 Current Assets 281.14 269.95 218.20 193.20 168.71 188.50 181.48 150.35 124.44 104.65 Current Investments 6.76 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 87.49 97.69 73.97 60.12 67.55 69.52 66.17 54.37 41.61 35.77 Sundry Debtors 103.10 94.84 77.91 69.44 51.66 65.69 64.06 61.01 56.82 44.99 Cash & Bank 13.13 7.35 5.09 3.72 2.95 4.09 4.02 4.61 4.46 4.54 Other Current Assets 70.65 11.03 12.25 9.49 46.55 49.21 47.23 30.37 21.54 19.35 Short Term Loans & Adv. 57.67 59.04 48.98 50.43 39.11 46.85 47.00 29.53 20.12 18.00 Net Current Assets 71.98 57.80 52.10 46.33 28.76 45.45 48.15 28.03 13.83 12.42 Total Assets 361.30 347.70 289.76 261.54 239.31 257.16 251.10 218.84 193.33 164.15

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 69.29 63.79 58.63 53.58 52.43 66.64 64.99 62.45 54.90 55.20 Share Capital 15.80 15.69 14.82 14.82 14.17 14.17 14.17 14.17 12.87 12.87 Total Reserves 53.49 48.10 42.87 37.82 38.25 52.47 50.82 48.27 40.01 40.31 Non-Current Liabilities 44.81 37.97 36.40 34.19 33.56 37.85 45.57 30.02 45.12 16.34 Secured Loans 24.41 14.11 27.01 23.93 22.93 28.76 33.25 12.76 15.24 6.11 Unsecured Loans 11.93 16.42 0.00 0.00 0.22 0.00 1.43 5.04 19.71 0.53 Long Term Provisions 5.09 5.07 4.69 4.07 3.62 2.71 2.05 3.42 2.28 1.65 Current Liabilities 203.04 209.33 165.65 152.53 159.49 163.24 154.40 143.24 111.19 92.36 Trade Payables 77.46 78.92 65.56 47.17 38.67 47.34 49.96 54.43 46.85 38.53 Other Current Liabilities 26.65 31.05 24.21 23.57 30.69 27.86 33.77 16.45 12.01 11.86 Short Term Borrowings 95.76 92.72 70.75 80.82 89.63 87.08 68.31 71.07 50.09 40.14 Short Term Provisions 3.17 6.64 5.12 0.98 0.50 0.96 2.37 1.29 2.24 1.83 Total Liabilities 317.11 311.00 260.55 240.07 238.38 261.31 260.17 233.33 211.03 163.87 Net Block 76.82 76.46 67.39 68.59 70.71 70.39 71.48 59.98 56.23 52.20 Gross Block 137.52 127.10 111.45 105.10 97.70 89.76 84.71 66.44 106.10 95.14 Accumulated Depreciation 60.70 50.64 44.06 36.52 27.00 19.37 13.23 6.46 49.87 42.95 Non Current Assets 82.97 82.85 75.96 75.93 81.02 78.26 75.41 68.78 68.03 58.74 Capital Work in Progress 0.47 0.00 1.61 0.00 3.32 3.63 0.21 1.70 3.93 0.77 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.02 Long Term Loans & Adv. 5.23 4.61 5.01 4.86 5.43 1.69 3.15 6.61 7.54 5.42 Other Non Current Assets 0.45 1.78 1.95 2.49 1.56 2.54 0.55 0.46 0.32 0.34 Current Assets 234.15 228.16 184.57 164.15 157.37 183.05 184.77 164.55 143.00 105.12 Current Investments 6.76 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 87.81 98.00 74.40 60.39 67.71 69.75 66.49 54.73 41.75 35.82 Sundry Debtors 99.62 93.98 75.31 67.20 49.60 64.70 64.05 61.80 56.94 44.98 Cash & Bank 13.29 7.61 5.39 3.85 3.13 4.32 4.15 4.71 4.63 5.49 Other Current Assets 26.66 3.73 12.49 4.69 36.92 44.28 50.07 43.31 39.66 18.83 Short Term Loans & Adv. 22.08 24.83 16.98 28.02 32.85 43.58 49.83 42.45 38.45 17.48 Net Current Assets 31.10 18.82 18.93 11.61 -2.12 19.81 30.36 21.31 31.81 12.77 Total Assets 317.12 311.01 260.53 240.08 238.39 261.31 260.18 233.33 211.03 163.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 28.95 5.38 30.57 10.23 21.71 11.55 12.57 6.36 1.28 14.38 PBT 12.11 8.55 12.06 9.80 -9.08 4.41 8.45 8.59 5.18 5.20 Adjustment 19.66 18.85 13.99 17.43 16.69 15.67 15.08 14.73 11.21 11.67 Changes in Working Capital 1.73 -21.52 5.64 -16.89 14.27 -6.16 -9.69 -15.56 -14.32 -1.18 Cash after chg. in Working capital 33.50 5.88 31.69 10.34 21.89 13.92 13.84 7.77 2.08 15.69 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.54 -0.50 -1.12 -0.11 -0.17 -2.38 -1.27 -1.40 -0.80 -1.31 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -18.43 -22.08 -13.43 -6.66 -3.16 -11.98 -15.59 -7.96 -13.73 -6.07 Net Fixed Assets -10.50 -13.94 -7.15 -3.66 -6.22 -4.61 -3.80 41.86 -12.93 -5.24 Net Investments -7.94 0.00 0.00 -0.98 0.02 0.00 -7.42 1.16 -0.09 -1.07 Others 0.01 -8.14 -6.28 -2.02 3.04 -7.37 -4.37 -50.98 -0.71 0.24 Cash from Financing Activity -7.71 17.12 -17.22 -3.36 -19.94 0.05 3.53 1.74 12.38 -6.80 Net Cash Inflow / Outflow 2.81 0.42 -0.08 0.21 -1.38 -0.38 0.51 0.15 -0.07 1.51 Opening Cash & Equivalents 1.23 0.81 0.89 0.68 2.20 2.58 2.07 4.46 4.54 3.02 Closing Cash & Equivalent 4.04 1.23 0.81 0.89 0.68 2.20 2.58 4.61 4.46 4.54

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 22.81 -1.54 26.80 22.34 23.24 7.76 0.58 6.31 -19.35 14.53 PBT 9.05 4.75 9.18 4.10 -13.53 -0.20 2.88 2.87 2.65 4.74 Adjustment 22.34 21.74 17.15 21.14 19.01 17.41 15.14 14.79 11.46 11.69 Changes in Working Capital -4.04 -27.52 1.66 -2.80 17.94 -7.07 -16.18 -9.95 -32.66 -0.59 Cash after chg. in Working capital 27.35 -1.03 28.00 22.45 23.42 10.13 1.84 7.72 -18.55 15.84 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.54 -0.50 -1.20 -0.11 -0.17 -2.38 -1.27 -1.40 -0.80 -1.31 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -18.89 -22.18 -9.48 -5.53 -4.71 -8.04 -3.56 -7.96 -13.88 -5.30 Net Fixed Assets -10.50 -13.94 -7.15 -3.66 -6.22 -4.61 -3.80 41.86 -12.93 -5.24 Net Investments -7.94 0.00 0.00 -0.98 0.02 0.00 -7.42 1.16 -0.09 -1.07 Others -0.45 -8.24 -2.33 -0.89 1.49 -3.43 7.66 -50.98 -0.86 1.01 Cash from Financing Activity -1.21 24.09 -17.22 -16.63 -19.97 0.01 3.53 -5.94 32.37 -6.80 Net Cash Inflow / Outflow 2.71 0.37 0.09 0.17 -1.44 -0.27 0.55 -7.58 -0.86 2.43 Opening Cash & Equivalents 1.49 1.11 1.02 0.86 2.44 2.71 2.16 -17.72 5.49 3.02 Closing Cash & Equivalent 4.20 1.49 1.11 1.02 0.86 2.44 2.71 -25.30 4.63 5.45

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 66.38 60.32 57.66 52.88 46.53 54.23 50.97 46.98 42.48 41.63 ROA 2.90% 1.92% 3.11% 3.63% -3.59% 2.66% 2.53% 2.58% 1.57% 2.52% ROE 10.30% 6.80% 10.47% 12.61% -12.47% 9.07% 8.56% 8.76% 5.18% 7.90% ROCE 11.95% 10.40% 12.28% 12.57% 2.09% 9.95% 11.76% 12.77% 10.07% 11.30% Fixed Asset Turnover 3.02 3.04 3.15 2.96 2.15 3.02 3.05 2.70 2.00 2.04 Receivable days 106.71 104.01 95.91 88.65 125.48 106.15 108.76 92.68 92.06 86.60 Inventory Days 99.83 103.36 87.29 93.46 146.56 111.00 104.83 75.50 69.97 64.59 Payable days 187.52 190.52 144.48 114.32 92.64 88.56 101.97 90.67 90.60 79.18 Cash Conversion Cycle 19.01 16.85 38.72 67.79 179.41 128.58 111.61 77.50 71.43 72.02 Total Debt/Equity 1.28 1.32 1.15 1.33 1.51 1.36 1.25 1.11 1.28 0.92 Interest Cover 1.79 1.68 2.14 1.81 0.29 1.35 1.90 2.02 1.80 1.80

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 43.84 40.66 38.92 35.52 36.99 47.02 45.86 44.06 41.09 41.32 ROA 2.37% 0.92% 2.28% 1.97% -5.16% 0.83% 0.15% -0.18% 0.14% 2.23% ROE 11.19% 4.31% 10.34% 8.97% -21.65% 3.27% 0.59% -0.69% 0.49% 7.00% ROCE 12.13% 9.56% 12.33% 9.72% -0.44% 6.88% 7.45% 7.59% 7.35% 10.88% Fixed Asset Turnover 2.56 2.55 2.60 2.47 1.83 2.58 2.80 2.72 2.01 2.06 Receivable days 104.16 101.56 92.48 85.08 121.92 104.42 108.60 92.23 91.87 86.58 Inventory Days 99.97 103.42 87.47 93.31 146.63 110.50 104.61 74.94 69.91 64.63 Payable days 162.36 165.90 132.11 111.21 90.28 86.70 99.47 88.16 89.31 79.05 Cash Conversion Cycle 41.77 39.08 47.85 67.18 178.27 128.22 113.74 79.02 72.47 72.17 Total Debt/Equity 2.01 2.05 1.80 2.09 2.26 1.85 1.69 1.49 1.68 0.93 Interest Cover 1.59 1.39 1.84 1.34 -0.06 0.98 1.31 1.34 1.41 1.73

Top Investors:

prakash chandra jain

ram keshav murthy

asha tapidas dodhia

gautam chand mehta

investor education and protection fund (iepf)

Annual Reports:

News Update:

Bal Pharma - Quarterly Results
11th Aug 2025, 18:09 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback